Background illustration for clinical trials search

Paid Clinical Trials Ogden

Discover 1,089 paid clinical trials in Ogden, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

for
Chronic Lymphocytic Leukemia (CLL),
Location: Salt Lake City UT, Denver CO, Duarte CA, Houston TX,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04830137

Phase 1, Recruiting

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

for
Non Small Cell Lung Cancer
Location: Salt Lake City UT, Reno NV, San Francisco CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312137

Phase 3, Recruiting

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

for
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma,
Location: Salt Lake City UT, Lancaster CA, Upland CA, Duarte CA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05890352

Phase 2, Recruiting

Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Salt Lake City UT, Sacramento CA, Houston TX,
Sponsor: OncoC4, Inc.

Sex: All

Age: 18+

Code: NCT06352359

Phase 1, Recruiting

Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression

for
Metastatic Prostate Cancer
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: Male

Age: 18+

Code: NCT06112990

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type

for
Cancer, Smoking
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06484179

Recruiting

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

for
Non-Small Cell Lung Cancer, NSCLC,
Location: Salt Lake City UT, Sacramento CA, San Francisco CA,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06917079

Phase 1, Recruiting

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

for
Recurrent or Metastatic Solid Tumors
Location: Salt Lake City UT, Wenatchee WA, Los Angeles CA,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06330064

Phase 1, Phase 2, Recruiting

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer,
Location: Salt Lake City UT, Aurora CO, Eugene OR,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06343402

Phase 1, Recruiting

AlloHCT With PegINFa for Myelofibrosis

for
Myelofibrosis
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT05535764

Phase 1, Recruiting

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

for
Metastatic Prostate Cancer
Location: Salt Lake City UT, Colorado Springs CO, Seattle WA,
Sponsor: ORIC Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT05413421

Phase 1, Recruiting

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer,
Location: Salt Lake City UT, Bullhead City AZ, Santa Fe NM,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222566

Phase 3, Recruiting

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

for
Anal Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm,
Location: Salt Lake City UT, San Francisco CA, La Jolla CA,
Sponsor: AIDS Malignancy Consortium

Sex: All

Age: 18+

Code: NCT05663502

Recruiting

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

for
Acute Myeloid Leukemia,
Location: Salt Lake City UT, Orange CA, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05886049

Phase 1, Recruiting

A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

for
Myelofibrosis, Moderate Thrombocytopenia, Mild Thrombocytopenia
Location: Salt Lake City UT, Duarte CA, Houston TX, Cleveland OH,
Sponsor: Karyopharm Therapeutics Inc

Sex: All

Age: 18+

Code: NCT05980806

Phase 2, Recruiting

Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR)

for
Central Nervous System Lymphoma
Location: Salt Lake City UT, Philadelphia PA, Providence RI
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06607549

Phase 1, Recruiting

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

for
Triple Negative Breast Cancer, Breast Cancer,
Location: Salt Lake City UT, Las Vegas NV, Spokane WA, Phoenix AZ,
Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05377996

Phase 1, Phase 2, Recruiting

Stereotactic Radiosurgery Dose Escalation for Brain Metastases

for
Brain Metastases
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT02390518

Phase 1, Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for
Breast Cancer
Location: Salt Lake City UT, Denver CO, Lone Tree CO, Parker CO,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase 3, Recruiting

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

for
Myelodysplastic Syndrome
Location: Salt Lake City UT, Boise ID, Meridian ID, Nampa ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06577441

Phase 2, Recruiting